HY-50® Vet: Advanced Joint Support with Sodium Hyaluronate
HY-50® Vet is a high-purity, high-dose sodium hyaluronate injection designed to support equine joint health. Used intra-articularly or intravenously, it enhances synovial fluid viscosity, reduces inflammation, and supports cartilage repair. Backed by clinical studies, HY-50® Vet provides veterinarians with a proven solution for managing lameness caused by joint dysfunction and non-infectious synovitis.
Osphos®: Proven Treatment for Navicular Syndrome
Osphos® (clodronate injection) is an intramuscular bisphosphonate therapy developed to control clinical signs of navicular syndrome in horses aged four years and older. By inhibiting bone resorption, it helps reduce lameness and improve long-term mobility. With robust efficacy studies showing lasting benefits for up to six months, Osphos® offers a safe, easy-to-administer solution for veterinarians treating bone-related lameness.
Equipalazone® – The First Choice Phenylbutazone for Equine Practice
Equipalazone® has been the trusted standard in equine pain and inflammation management for more than 30 years. Its patented MICROCAPS® technology ensures excellent palatability and compliance, while providing proven anti-inflammatory and analgesic relief for musculoskeletal disorders including laminitis, osteoarthritis, bursitis, and post-surgical inflammation. With over 10 million sachets consumed annually and a strong safety record since 1972, Equipalazone® remains the reliable solution for veterinary professionals.
Loading...
Vacancies
Applications will only be accepted for advertised positions, by submission through our careers page.
We encourage you to keep an eye on our careers page for future openings that match your skills and experience.